Stocks and Investing Stocks and Investing
Mon, January 29, 2024

Eric Joseph Upgraded (CCCC) to Hold and Held Target at $6 on, Jan 29th, 2024


Published on 2024-10-28 08:36:20 - WOPRAI, Eric Joseph
  Print publication without navigation


Eric Joseph of JP Morgan, Upgraded "C4 Therapeutics, Inc." (CCCC) to Hold and Held Target at $6 on, Jan 29th, 2024.

Eric has made no other calls on CCCC in the last 4 months.



There are 5 other peers that have a rating on CCCC. Out of the 5 peers that are also analyzing CCCC, 2 agree with Eric's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Terence Flynn of "Morgan Stanley" Upgraded from Sell to Hold and Decreased Target to $1 on, Monday, November 6th, 2023
  • Chi Fong of "B of A Securities" Maintained at Hold with Decreased Target to $2 on, Monday, October 9th, 2023


These are the ratings of the 3 analyists that currently disagree with Eric


  • Bradley Canino of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $12 on, Wednesday, December 13th, 2023
  • Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $16 on, Friday, November 3rd, 2023
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $7 on, Thursday, November 2nd, 2023
Contributing Sources